Clinical Challenges: Test Your Knowledge of Acute Myeloid Leukemia

Latest Posts

Largest COVID Vax Safety Study; Kratom Deaths Rising; Gov. Threatens Hospital Chain

By Lizzy

Note that some links may require registration or subscription. An analysis based on 99 million people globally who received COVID-19 vaccines confirmed previously established safety...

Comments closed

Fasting-like diet lowers risk factors for disease, reduces biological age in humans

By Sheela

Cycles of a diet that mimics fasting can reduce signs of immune system aging, as well as insulin resistance and liver fat in humans, resulting...

Comments closed

Junk DNA in birds may hold key to safe, efficient gene therapy

By Sheela

The recent approval of a CRISPR-Cas9 therapy for sickle cell disease demonstrates that gene editing tools can do a superb job knocking out genes to...

Comments closed

Researchers are using RNA in a new approach to fight HIV

By Sheela

Society learned about the value of mRNA during the COVID-19 pandemic when we saw scientists and medical professionals harness its power to deliver a vaccine...

Comments closed

Nearly all doctors feel burnout, but many are encouraged by potential of AI, survey says

By Sheela

Suriyapong Thongsawang | Moment | Getty ImagesDoctors in the U.S. are struggling to contend with burnout, staffing shortages and overwhelming administrative workloads, but many are...

Comments closed

A MedPage Today Clinical Challenges series on acute myeloid leukemia (AML) looked at early mortality in acute promyelocytic leukemia, AML maintenance therapy, and investigational strategies for treating TP53-mutated disease.

The following is a three-question quiz to test your knowledge on each aspect of the series. Correct answers and explanations appear after completing the quiz.

Mike Bassett is a staff writer focusing on oncology and hematology. He is based in Massachusetts.

Source: MedicalNewsToday.com